AI辅助LC-OCT诊断基底细胞癌的多中心回顾性研究
该多中心回顾性研究纳入200例可疑基底细胞癌(BCC)皮损,43名皮肤科医生通过双轮测验比较临床与皮肤镜图像(C&D)、LC-OCT及AI辅助LC-OCT的诊断表现。结果显示AI辅助LC-OCT较C&D显著提高BCC诊断敏感性(+25.8点)和特异性(+16.8点),尤其惠及LC-OCT经验较少者,有效弥补约2年经验差距。
要点
- AI辅助LC-OCT较传统C&D显著提升BCC诊断敏感性(+25.8点)和特异性(+16.8点)。
- AI辅助对LC-OCT经验较少的医生帮助更大,可弥补约2年经验差距。
- AI辅助LC-OCT有望减少活检需求、加速临床决策并优化手术方案。
核心结论
- AI辅助LC-OCT可显著改善皮肤科医生对可疑BCC皮损的诊断表现,尤其对LC-OCT经验较少者帮助更大。
- 结果支持通过AI辅助更广泛地在临床实践中采用LC-OCT,并有望减少侵入性操作需求、改善患者结局。
研究设计与样本
- 多中心回顾性研究,纳入来自法国、西班牙、意大利和比利时四家医院的200例可疑BCC皮损。
- 43名不同LC-OCT经验水平的皮肤科医生参与双轮测验,通过专用网络应用先基于C&D图像、再随机基于LC-OCT或AI辅助LC-OCT做出BCC二分类诊断。
主要发现
- AI辅助LC-OCT较C&D相比,诊断BCC的敏感性提高25.8点、特异性提高16.8点。
- AI辅助尤其惠及LC-OCT经验较少的医生,有效弥补约2年的经验差距。
- LC-OCT在诊断可疑皮损中的BCC表现优于传统影像方法。
关键数值与推荐
- AI辅助LC-OCT较C&D:敏感性+25.8点,特异性+16.8点。
- AI辅助可弥补约2年的LC-OCT经验差距。
临床怎么用
- 临床可借助实时AI辅助LC-OCT提高对可疑BCC皮损的无创诊断准确性,减少对活检的依赖。
- AI辅助有助于加速临床决策、指导治疗选择并优化手术方案,尤其适合LC-OCT经验较少的医生。
局限性
- 本研究为回顾性设计,结果需前瞻性研究进一步验证。
- 研究仅纳入可疑BCC皮损,结论外推至其他皮肤病变或更广泛人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Basal cell carcinoma (BCC) is the most common skin cancer, requiring an early diagnosis and accurate margin definition to prevent functional and cosmetic complications. Traditional methods using clinical and dermoscopic images (C&D) often rely on biopsies and histology for final validation. Non-invasive techniques like LC-OCT, enabling 'digital biopsies', are promising alternatives, but remain underutilized due to the expertise required. The development of Artificial Intelligence (AI) algorithms is a promising approach to assist dermatologists in their diagnosis and support the broader adoption of such technologies. OBJECTIVES: We present a real-time AI assistant for BCC diagnosis with LC-OCT, which is, to date, the only real-time AI model across all dermatological imaging modalities. The study aims to quantify the model's effectiveness when used by dermatologists with different levels of expertise and compare its performance with traditional methods and unaided LC-OCT. METHODS: This multicenter, retrospective study involved 43 dermatologists in a double-rounded quiz on 200 equivocal BCC lesions. Diagnoses were first made on C&D images, then with LC-OCT or AI-assisted LC-OCT in a randomized manner. RESULTS: AI-assisted LC-OCT significantly improves dermatologists' diagnostic performance in detecting BCC (+25.8 points in sensitivity and +16.8 points in specificity compared to C&D), particularly benefiting those with less LC-OCT experience, effectively bridging a 2-year gap of expertise. These results highlight the potential for broader clinical adoption through AI assistance and underscore its promise in reducing the need for invasive procedures and improving patient outcomes. CONCLUSIONS: These results support a broader adoption of LC-OCT use in clinical practice thanks to AI assistance and underscore its promise in reducing the need for invasive procedures and improving patient outcomes. Basal cell carcinoma (BCC) is the most common skin cancer. Although rarely deadly, it can progressively invade surrounding tissues such as cartilage and bone. Early and accurate diagnosis is essential to avoid complications such as functional loss or significant cosmetic damage. This study includes clinical and LC‐OCT data from 200 suspicious lesions for BCC, collected across four hospitals in France, Spain, Italy and Belgium. Its goal is to retrospectively quantify the effect of real‐time AI assistance with LC‐OCT on the diagnostic efficacy of dermatologists with different levels of expertise with this technology. Forty‐three dermatologists evaluated the 200 lesions using traditional imaging methods (clinical photography and dermoscopy) as well as LC‐OCT, through a dedicated web application. They had to give a binary decision for BCC at two different stages, with traditional images alone and with LC‐OCT videos. Half of the time, LC‐OCT images were accompanied by an AI assistant. The analysis of the diagnostic results across the different scenarios demonstrated that LC‐OCT outperforms traditional imaging for diagnosing BCC in equivocal lesions. It also showed that AI assistance provides significant help to dermatologists and more particularly those with less experience in LC‐OCT, by improving their diagnostic precision. AI support could make LC‐OCT easier to interpret and improve BCC detection. This may reduce the need for skin biopsies, accelerate clinical decision‐making and improve patient care by guiding treatment selection and optimizing surgical procedures.
引用
- Fischman S, Viel T, Perrot JL, et al. AI-assisted basal cell carcinoma diagnosis with LC-OCT: A multicentric retrospective study. J Eur Acad Dermatol Venereol. 2025. PMID: 41109970. doi:10.1111/jdv.70099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。